Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products.
FDA Approves Ocrevus Zunovo (ocrelizumab & hyaluronidase-ocsq) Twice-A-Year Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis
September 13, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the United States Food and Drug Administration...
FDA Approves Ebglyss (lebrikizumab-lbkz) for the Treatment of Atopic Dermatitis
Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved Ebglyss (lebrikizumab-lbkz), a targeted IL-13...
Workplace Stress Triggers: How to Spot Them, How to Cope
Workplace anxiety. Who hasn't experienced it?However, if that anxiety is so strong that it hurts your performance or lingers for months, you might have...
Stroke Was Third Most Common GBD Level 3 Cause of Death in 2021
The global burden of stroke is considerable, according to a study published in the October issue of The Lancet Neurology. Valery L. Feigin, M.D., Ph.D.,...
No Perinatal Risks Seen With Influenza Vaccination in Successive Pregnancies
Influenza vaccination in successive pregnancies is not associated with increased risk for prespecified adverse perinatal outcomes, according to a study...
FDA Approves First Flu Vaccine That Can Be Self-Administered at Home
On Friday, the U.S. Food and Drug Administration approved the FluMist nasal vaccine for self-administration at home. It is a "new option for receiving...
FDA Approves First Flu Vaccine You Give Yourself at Home, FluMist
The days of waiting for a flu shot at your doctor's office or local pharmacy may be over: The U.S. Food and Drug Administration on Friday approved FluMist...
High Levels of Well-Being Protect Against Cardiovascular Disease
High levels of well-being may protect against the risks for cardiovascular diseases (CVDs), according to a study published online Sept. 18 in the Journal...
Stroke Rates Rising in Adults and Kids With Sickle Cell Disease
Stroke rates continue to rise among adults and children living with sickle cell disease, despite new standards of care meant to lower their risk, a new...
FDA Says Drug Makers Will Stop Producing Fentanyl 'Lollipops'
Controversial fentanyl lollipops and similar products will no longer be made by drug makers, the U.S. Food and Drug Administration has announced. Known...
Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class Drug Treatment for Idiopathic Pulmonary Fibrosis (IPF) Designed Using Generative AI
CAMBRIDGE, Mass., Sept. 18, 2024. Insilico Medicine, a clinical-stage generative AI-driven drug discovery company, announced positive preliminary results...
Bionpharma Inc. Issues Voluntary Nationwide Recall of Atovaquone Oral Suspension Due to Bacterial Contamination
September 17, 2024 – Princeton, NJ, Bionpharma Inc. is voluntarily recalling (1) single Batch (2310083) of Atovaquone Oral Suspension, 750mg per...
Ascletis Enters the Obesity Drug Space with Announcement of Two Ongoing U.S. Phase I Clinical Trials Utilizing Its Small Molecule GLP-1R Agonist ASC30
HONG KONG, Sept. 17, 2024. Ascletis Pharma Inc. ("Ascletis") announces today completion of initial dosing in its two recently initiated U.S. Phase I clinical...
Expert Advice on Preparing for the Fall COVID, Flu Season
People should prepare for the fall cold and flu season by getting the updated influenza and COVID-19 vaccinations, an infectious diseases expert says. “When...
Recently Added
Recently added consumer and prescribing information: Pavblu, Livdelzi, Yorvipath, Crexont, Lymphir, Epysqli, Pyzchiva, Ahzantive, Ohtuvayre, Sofdra
For Consumers
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- Natural Product Information for the Consumer
For Professionals
- FDA Professional Information
- Professional Patient Advice
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- Natural Product Information
For Researchers
Latest FDA New Drug Approvals
- Ocrevus Zunovo Ocrevus Zunovo (ocrelizumab & hyaluronidase-ocsq) is a CD20-directed cytolytic antibody and hyaluronidase combination used for the...
- Ebglyss Ebglyss (lebrikizumab-lbkz) is a targeted IL-13 inhibitor used for the treatment of moderate-to-severe atopic dermatitis (eczema) in adults...
- Pavblu Pavblu (aflibercept-ayyh) is a vascular endothelial growth factor (VEGF) inhibitor biosimilar to Eylea indicated for the treatment of...
Drugs in Development (Not yet approved)
- Yutrepia Yutrepia (treprostinil) is an inhaled dry powder formulation of treprostinil tentatively approved for the treatment of pulmonary arterial...